Pacific Shuanglin Bio-pharmacy Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000F14
CNY
14.55
-0.2 (-1.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,632.62
2,307.03
2,388.39
1,956.46
1,042.75
908.56
852.92
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,632.62
2,307.03
2,388.39
1,956.46
1,042.75
908.56
852.92
Raw Material Cost
1,387.14
1,173.38
1,190.85
1,099.77
559.20
459.31
428.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
169.63
167.19
161.39
157.66
96.73
87.89
111.55
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.22
9.98
12.27
12.61
19.37
21.92
26.12
Selling and Distribution Expenses
403.05
427.33
542.47
393.19
251.51
240.48
284.98
Other Expenses
-13.29
-10.57
-10.33
-13.59
-10.60
-9.63
-11.14
Total Expenditure (Excl Depreciation)
1,838.18
1,672.17
1,803.67
1,527.37
820.82
713.31
739.98
Operating Profit (PBDIT) excl Other Income
794.4
634.9
584.7
429.09999999999997
221.9
195.2
112.89999999999999
Other Income
64.22
82.20
83.43
72.62
19.38
20.34
4.63
Operating Profit (PBDIT)
993.27
863.15
798.96
624.35
297.02
266.01
176.21
Interest
11.22
9.98
12.27
12.61
19.37
21.92
26.12
Exceptional Items
6.59
-18.97
4.51
-30.58
-4.73
-0.28
4.27
Gross Profit (PBDT)
1,245.48
1,133.65
1,197.55
856.69
483.55
449.25
424.24
Depreciation
135.87
146.08
130.81
123.15
55.72
54.80
58.64
Profit Before Tax
852.78
688.11
660.39
458.01
217.19
189.01
95.72
Tax
107.74
76.64
72.70
66.47
34.51
31.17
22.65
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
745.32
612.11
587.13
391.06
185.97
160.45
79.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
745.32
612.11
587.13
391.06
185.97
160.45
79.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.28
-0.64
0.56
0.48
-3.28
-2.61
-5.04
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
745.04
611.47
587.69
391.54
182.68
157.84
74.94
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,924.65
7,428.65
6,867.52
6,325.66
965.32
800.22
639.77
Earnings per share (EPS)
0.78
0.65
0.62
0.43
0.29
0.25
0.13
Diluted Earnings per share
0.78
0.65
0.62
0.43
0.29
0.25
0.13
Operating Profit Margin (Excl OI)
30.13%
27.52%
24.48%
21.91%
21.28%
21.01%
13.24%
Gross Profit Margin
37.55%
36.16%
33.13%
29.7%
26.17%
26.83%
18.1%
PAT Margin
28.31%
26.53%
24.58%
19.99%
17.83%
17.66%
9.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 14.11% vs -3.41% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 21.83% vs 4.05% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 18.96% vs 9.15% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 12.00% vs -18.70% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Pacific Shuanglin Bio-pharmacy Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,632.62
0
2,632.62
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,632.62
0
2,632.62
Raw Material Cost
1,387.14
0
1,387.14
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
169.63
0
169.63
Power Cost
0
0
0.00
Manufacturing Expenses
11.22
0
11.22
Selling and Distribution Expenses
403.05
0
403.05
Other Expenses
-13.29
0.00
-13.29
Total Expenditure (Excl Depreciation)
1,838.18
0
1,838.18
Operating Profit (PBDIT) excl Other Income
794.44
0.00
794.44
Other Income
64.22
0
64.22
Operating Profit (PBDIT)
993.27
0
993.27
Interest
11.22
0
11.22
Exceptional Items
6.59
0
6.59
Gross Profit (PBDT)
1,245.48
0
1,245.48
Depreciation
135.87
0
135.87
Profit Before Tax
852.78
0
852.78
Tax
107.74
0
107.74
Provisions and contingencies
0
0
0.00
Profit After Tax
745.32
0
745.32
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
745.32
0
745.32
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.28
0
-0.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
745.04
0
745.04
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,924.65
0
7,924.65
Earnings per share (EPS)
0.78
0
0.78
Diluted Earnings per share
0.78
0
0.78
Operating Profit Margin (Excl OI)
30.13%
0%
0.00
30.13%
Gross Profit Margin
37.55%
0%
0.00
37.55%
PAT Margin
28.31%
0%
0.00
28.31%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 263.26 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 14.11% vs -3.41% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 74.50 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.83% vs 4.05% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 92.91 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 18.96% vs 9.15% in Dec 2023

Annual - Interest
Interest 1.12 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 12.00% vs -18.70% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.13%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023